AVCRF (Avricore Health) Notes Receivable: $0.00 Mil (As of Mar. 2026)


What is Avricore Health Notes Receivable?

Avricore Health AVCRF +5.75% Notes Receivable is $0.00 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Avricore Health's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Avricore Health Notes Receivable Related Terms

Avricore Health Notes Receivable Historical Data

* Premium members only.

The historical data trend for Avricore Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health Notes Receivable Chart

Avricore Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Avricore Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Avricore Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Avricore Health (AVCRF) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Avricore Health and its competitors.
Is Avricore Health's Notes Receivable too high?
Avricore Health's current Notes Receivable is $0.00 Mil.
How does Avricore Health's Notes Receivable compare to TMO and DHR?
Avricore Health's Notes Receivable of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Avricore Health and its competitors. Avricore Health's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (AVCRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.03 — trading 247.7% above its estimated fair value. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Avricore Health (AVCRF), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avricore Health Business Description

Other Exchanges AVCR:Canada
Address 1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.